• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: MEDTRONIC HEART VALVES DIVISION EVOLUT FX DCS; AORTIC VALVE, PROSTHESIS, PERCUTANEOUSLY DELIV

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

MEDTRONIC HEART VALVES DIVISION EVOLUT FX DCS; AORTIC VALVE, PROSTHESIS, PERCUTANEOUSLY DELIV Back to Search Results
Model Number D-EVOLUTFX-2329
Device Problems Failure to Advance (2524); Patient Device Interaction Problem (4001)
Patient Problem Vascular Dissection (3160)
Event Date 03/22/2024
Event Type  Injury  
Event Description
Medtronic received information that during the implant of this transcatheter bioprosthetic valve, the patient had extremely calcified vessels that the magnitude of which was not originally appreciated via computed tomography (ct) scan.Ct scan showed calcified vessels but no less than 5mm throughout.The minimum diameter of the access vessel was reported as 4.8/6.3mm.Access on the right femoral artery was easily achieved and a 14f sheath was easily inserted into right common femoral artery.The delivery catheter system (dcs) was advanced through the femoral, external, and common arteries with ease.The dcs would not advance through the abdominal aorta due to calcium throughout.After multiple attempts, buddy wire with a lunderquist wire placed, the decision was made to abort the procedure.After assessment of the vessels, the right common femoral artery was dissected and treated with a graft.The dissection occurred during removal of the dcs.Prolonged hospitalization was required and a procedural delay occurred as a result of aborted transcatheter aortic valve replacement (tavr).No additional adverse patient effects were reported.
 
Manufacturer Narrative
Medtronic submits this report to comply with fda regulations 21 cfr parts 4 and 803.Medtronic has made reasonable efforts to provide as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.Medtronic will submit a supplemental report if additional relevant information becomes known.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
EVOLUT FX DCS
Type of Device
AORTIC VALVE, PROSTHESIS, PERCUTANEOUSLY DELIV
Manufacturer (Section D)
MEDTRONIC HEART VALVES DIVISION
1851 e deere ave
santa ana CA 92705
Manufacturer (Section G)
MEDTRONIC HEART VALVES DIVISION
1851 e deere ave
santa ana CA 92705
Manufacturer Contact
alison sweeney
parkmore business park west
galway 
EI  
091708096
MDR Report Key19007149
MDR Text Key338981224
Report Number2025587-2024-02002
Device Sequence Number1
Product Code NPT
UDI-Device Identifier00763000365677
UDI-Public00763000365677
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
P130021
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Health Professional
Reporter Occupation Physician
Type of Report Initial
Report Date 03/29/2024
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received03/29/2024
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Model NumberD-EVOLUTFX-2329
Device Catalogue NumberD-EVOLUTFX-2329
Device Lot Number0012101419
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received03/22/2024
Date Device Manufactured01/08/2024
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention; Hospitalization;
Patient Age78 YR
Patient SexFemale
Patient Weight79 KG
-
-